A detailed history of Artia Global Partners LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Artia Global Partners LP holds 45,000 shares of NBIX stock, worth $5.65 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
45,000
Previous 45,000 -0.0%
Holding current value
$5.65 Million
Previous $6.2 Billion 16.31%
% of portfolio
1.41%
Previous 1.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $4.8 Million - $5.72 Million
45,000 New
45,000 $5.37 Billion

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.